Nitrosamines, Elemental Impurities, Extractable and Leachable – A New Normal for the Pharma Industry
Summary: In this webinar, experts will discuss the current regulatory expectations for E&L, elemental impurities and nitrosamines testing, as well as the latest advances in analytical methods. The speakers will also provide practical recommendations for implementing risk-based approaches to E&L, elemental impurities and nitrosamines testing in small molecule drug development. In addition, experts will share insights on how to expedite turnaround times during testing of pharmaceutical products while preserving product quality and safety.